Literature DB >> 1879597

Increased plasma levels of the novel vasoconstrictor peptide endothelin in severe pre-eclampsia.

G A Dekker1, A A Kraayenbrink, G G Zeeman, G J van Kamp.   

Abstract

Plasma endothelin levels were studied in 29 pregnancies. Levels were found to be increased in 9 pregnancies complicated by pregnancy-induced hypertensive disease and/or pre-eclampsia as compared to levels in 14 normotensive pregnancies with gestational age varying between 24-40 weeks with normal Doppler flow velocity waveforms of the uterine arcuate arteries, and 6 normotensive pregnancies with abnormal Doppler flow velocity waveforms at 24 weeks' gestation. Two patients with severe pre-eclampsia showed a rise in plasma endothelin levels, suggesting a correlation between plasma endothelin levels and the disease process. Endothelin is produced by endothelial cells of blood vessels; it is the most potent vasoconstrictor known to date. For this reason it has been suggested that endothelin might be important in the control of systemic blood pressure and local blood flow, both disturbed in pre-eclampsia. The conclusion of this study is that the venous plasma level of endothelin would seem to be a marker for severe disease, however, without any predictive value.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1879597     DOI: 10.1016/0028-2243(91)90120-a

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  11 in total

Review 1.  Preeclampsia. Still an enigma.

Authors:  J Duda
Journal:  West J Med       Date:  1996-04

2.  Autoantibody-mediated IL-6-dependent endothelin-1 elevation underlies pathogenesis in a mouse model of preeclampsia.

Authors:  Cissy Chenyi Zhou; Roxanna A Irani; Yingbo Dai; Sean C Blackwell; M John Hicks; Susan M Ramin; Rodney E Kellems; Yang Xia
Journal:  J Immunol       Date:  2011-04-11       Impact factor: 5.422

3.  Hypertension in response to placental ischemia during pregnancy: role of B lymphocytes.

Authors:  Babbette LaMarca; Kedra Wallace; Florian Herse; Gerd Wallukat; James N Martin; Abram Weimer; Ralf Dechend
Journal:  Hypertension       Date:  2011-02-28       Impact factor: 10.190

4.  Role of endothelin in mediating soluble fms-like tyrosine kinase 1-induced hypertension in pregnant rats.

Authors:  Sydney R Murphy; B Babbette D LaMarca; Kathy Cockrell; Joey P Granger
Journal:  Hypertension       Date:  2009-12-21       Impact factor: 10.190

5.  Advanced glycation end products upregulate lysyl oxidase and endothelin-1 in human aortic endothelial cells via parallel activation of ERK1/2-NF-κB and JNK-AP-1 signaling pathways.

Authors:  Christos Adamopoulos; Christina Piperi; Antonios N Gargalionis; Georgia Dalagiorgou; Eliana Spilioti; Penelope Korkolopoulou; Evanthia Diamanti-Kandarakis; Athanasios G Papavassiliou
Journal:  Cell Mol Life Sci       Date:  2015-12-08       Impact factor: 9.261

6.  Role of reactive oxygen species in gynecologic diseases.

Authors:  Rakesh K Sharma; Ashok Agarwal
Journal:  Reprod Med Biol       Date:  2004-12-03

Review 7.  The role of inflammation in the pathology of preeclampsia.

Authors:  Ashlyn C Harmon; Denise C Cornelius; Lorena M Amaral; Jessica L Faulkner; Mark W Cunningham; Kedra Wallace; Babbette LaMarca
Journal:  Clin Sci (Lond)       Date:  2016-03       Impact factor: 6.124

8.  SFlt-1 elevates blood pressure by augmenting endothelin-1-mediated vasoconstriction in mice.

Authors:  Fouad Amraoui; Léon Spijkers; Hajar Hassani Lahsinoui; Liffert Vogt; Joris van der Post; Stephan Peters; Gijs Afink; Carrie Ris-Stalpers; Bert-Jan van den Born
Journal:  PLoS One       Date:  2014-03-14       Impact factor: 3.240

9.  The level of maternal methemoglobin during pregnancy in an air-polluted environment.

Authors:  Lucijan Mohorovic
Journal:  Environ Health Perspect       Date:  2003-12       Impact factor: 9.031

10.  Preeclampsia: From Inflammation to Immunoregulation.

Authors:  Denise C Cornelius
Journal:  Clin Med Insights Blood Disord       Date:  2018-01-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.